Clinical effect of different concentrations of ropivacaine in the labor analgesia of dural puncture epidural technique for obese puerperae

Table 1 Comparison of the maternal general conditions

General information	Group A (n = 50)	Group B (n = 50)	Group C (n = 50)	P value
Age (year)	29.20 ± 2.79	30.14 ± 3.23	29.50 ± 3.04	0.289
BMI (kg/m²)	31.96 ± 1.73	32.12 ± 1.77	32.28 ± 1.86	0.549
Gestational week (week)	39.46 ± 0.97	39.54 ± 1.03	39.28 ± 1.18	0.459
ASA I/II class	21/29	27/23	20/30	0.315
Hypertension [case (%)]	12 (24.00%)	10 (20.00%)	14 (28.00%)	0.645
Diabetes [case (%)]	19 (38.00%)	20 (40.00%)	17 (34.00%)	0.819

BMI body mass index, ASA American Society of Anaesthesiologists, Group A 0.075% ropivacaine + 0.5 μg/ml sufentanil; Group B 0.10% ropivacaine + 0.5 μg/ml sufentanil; Group C 0.125% ropivacaine + 0.5 μg/ml sufentanil

ISSN: 2047-0525